Search

Your search keyword '"Hagenacker, Tim"' showing total 571 results

Search Constraints

Start Over You searched for: Author "Hagenacker, Tim" Remove constraint Author: "Hagenacker, Tim"
571 results on '"Hagenacker, Tim"'

Search Results

5. 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2

7. Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study

8. Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment

9. Versorgung von Patienten mit kardialer Amyloidose: Konsensuspapier der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), AG 40 Onkologische Kardiologie, und der Deutschen Gesellschaft für Hämatologie und medizinische Onkologie e. V. (DGHO), der Deutschen Gesellschaft für Neurologie e. V. (DGN) und der Deutschen Gesellschaft für Nephrologie e. V. (DGfN)

11. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany

15. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study

16. Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program

22. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis

23. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

24. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

28. 18F-flutemetamol positron emission tomography in cardiac amyloidosis

33. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

34. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

40. Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature

42. Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy

44. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study

45. Versorgung von Patienten mit kardialer Amyloidose

50. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial

Catalog

Books, media, physical & digital resources